BioSpace News Archive

Biotech Beach

Tarsus to Present at Upcoming Investor Conferences - Mar 09, 2022

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced management will present at the following conferences.

March 9, 2022
·
1 min read
Genetown

Stealth BioTherapeutics to Present at Upcoming March 2022 Investor Conferences

Stealth BioTherapeutics Corp announced that Reenie McCarthy, CEO, will present at three upcoming investor conferences in March.

March 9, 2022
·
2 min read
Drug Development

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), today announced that China National Medical Products Administration (NMPA) has approved the Phase I study of ATG-101 (the PROBE-CN study) for the treatment of advanced/ metastatic solid tumors and B-cell non-Hodgkin lymphoma (B-NHL).

March 9, 2022
·
6 min read
Increased Use For Security And Surveillance In Healthcare Industry Is Expected To Drive Infrared Imaging Market Revenue Growth In Near Future– Reports And Data

Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs of the global population.

March 9, 2022
·
7 min read
Pharmaceutical Packaging Market Size 2021 - Growth, Trends, COVID-19 Impact, and Forecasts by 2028

The report carefully investigates the present market scenario and the fundamental growth prospects. The report entails an organized database of the Pharmaceutical Packaging market dynamics that helps market analysts estimate the global market growth rate over the projected timeline.

March 9, 2022
·
6 min read
Rakovina Therapeutics to Present Abstract at the 2022 Annual Meeting of the American Association of Cancer Research (AACR)

Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce the acceptance of a new abstract to be presented at the 2022 AACR Annual Meeting.

March 9, 2022
·
3 min read
Business

electroCore Announces Changes to its Board of Directors

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced the appointment of Julie Bruzzone Goldstein and Tricia Wilber to the company’s Board of Directors effective March 15, 2022.

March 9, 2022
·
5 min read
Pharm Country

Nevakar Announces Closing of $12 Million Convertible Note and Extension of Interest-Only Period with Oxford Finance

Nevakar Inc., a biopharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced that it has closed on $12 million in convertible notes with both existing and new investors.

March 9, 2022
·
2 min read
Neuroprosthetics Market Increased R&D and Launch of New Ways to Access CNS and PNS Opens New Opportunities

The rise in healthcare awareness and prevalence of chronic diseases has increased the demand for neuroprosthetic devices and implants.

March 9, 2022
·
3 min read
Partnership strategy to expand portfolio of digital pathology solutions

Digital pathology is a boon for pathologists and patients as it enables rapid diagnosis. Advanced technologies such as artificial intelligence (AI) and others will be utilized for offering better services than before.

March 9, 2022
·
2 min read